Cyberna
Developing epitranscriptomics-based early cancer screening tools for patients and healthcare providers
Highlights
- Young companyFounded 2023
- New on EvolcAdded 2026-11-10
About Cyberna
Cyberna is developing a diagnostic platform that combines multiplex mass spectrometry and machine learning to identify RNA-modification signatures in blood for early cancer detection. The company describes its workflow as applicable across cancer types and requiring a small blood sample.
Its screening tools are intended for patients and healthcare providers. The company was founded in December 2023 after four years of research and development in applied epitranscriptomics, and is based in Montpellier, France.
Product: A diagnostic platform using multiplex mass spectrometry and machine learning to identify epitranscriptomic signatures for early cancer screening.
Jobs at Cyberna
More biotech & pharma companies
Cynbiose
Preclinical research services using non-human primate models for biopharmaceutical and life sciences developersCytoo
Muscle disease drug-discovery services and micropattern products for pharmaceutical, biotechnology and research organizationsDarewin Evolution
AI-guided microalgae strain selection and improvement for producers in food, nutraceuticals, cosmetics and bioremediationYoung companyNew on EvolcDBV Technologies
Clinical-stage biopharma developing the VIASKIN patch for food allergies and other immunological diseasesDeeplife
AI-driven cell digital twins and multi-omics analysis for pharmaceutical drug discovery and developmentDeeptope
High-throughput antibody characterization and optimization for biotechnology and pharmaceutical developersNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Backend
- PHPHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerx-powered-by
Content management
- ElementorHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
- WordPressHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Frontend frameworks
- jQueryHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Hosting
- ApacheHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerserver
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.
